Radical prostatectomy in T4 prostate cancer after inductive androgen deprivation: results of a single-institution series with long-term follow-up

被引:21
|
作者
Hajili, Turkan [1 ]
Ohlmann, Carsten H. [1 ]
Linxweiler, Johannes [1 ]
Niklas, Christina [1 ]
Janssen, Martin [1 ]
Siemer, Stefan [1 ]
Stoeckle, Michael [1 ]
Saar, Matthias [1 ]
机构
[1] Saarland Univ, Dept Urol & Pediat Urol, D-66421 Homburg, Germany
关键词
inductive androgen deprivation; inoperable high-risk prostate cancer; prostate-specific antigen nadir; radical prostatectomy; #pcsm; #ProstateCancer; NEOADJUVANT HORMONAL-THERAPY; HIGH-RISK; PHASE-II; MEN; SURVIVAL; ADENOCARCINOMA;
D O I
10.1111/bju.14393
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
ObjectivesTo determine the outcomes of complete surgical resection of T4 prostate cancer after inductive androgen-deprivation therapy (ADT), as inductive ADT and subsequent radical prostatectomy (RP) is not recommended by any guideline yet. Patients and MethodsA monocentric RP database was queried for patients initially diagnosed with T4 prostate cancer, considered primarily as inoperable because of a fixed mass defined by rectal examination in combination with high PSA level and/or large foci of biopsy confirmed undifferentiated prostate cancer. Treatment consisted of primary ADT until PSA nadir with consecutive RP. Patients underwent retropubic RP (RRP) or robot-assisted laparoscopic RP (RALP) after inductive ADT until achievement of the PSA nadir, which is in general reached after 6-7months. The intraoperative course and complications were analysed. Finally, Kaplan-Meier estimates were calculated for overall survival (OS) and prostate cancer-specific survival (PCSS). ResultsWe retrospectively identified 116 patients treated between 2000 and 2014. At diagnosis, the median (range) PSA level was 37.6 (2.44-284) ng/mL. The preoperative median (range) PSA after inductive ADT was 0.73 (0.01-34) ng/mL. Thereafter, patients underwent RRP or, since 2006, RALP. The median (95% confidence interval) OS was 156 (118.9-193.1) months. The PCSS at 150months was 82%. ConclusionsSurgical therapy of primarily inoperable prostate cancer is feasible and safe after inductive ADT. The OS of this cohort seems comparable with results described for patients with primary operable high-risk prostate cancer.
引用
收藏
页码:58 / 64
页数:7
相关论文
共 50 条
  • [1] Radical Prostatectomy in Men with Oligometastatic Prostate Cancer: Results of a Single-institution Series with Long-term Follow-up
    Gandaglia, Giorgio
    Fossati, Nicola
    Stabile, Armando
    Bandini, Marco
    Rigatti, Patrizio
    Montorsi, Francesco
    Briganti, Alberto
    EUROPEAN UROLOGY, 2017, 72 (02) : 289 - 292
  • [2] Long-term follow-up of radical retropubic prostatectomy for prostate cancer
    Swanson, GP
    Riggs, MW
    Earle, JD
    Haddock, MG
    EUROPEAN UROLOGY, 2002, 42 (03) : 212 - 216
  • [3] Long-term follow-up comparing salvage radiation therapy and androgen-deprivation therapy for biochemical recurrence after radical prostatectomy
    Matsumoto, Kazuhiro
    Niwa, Naoya
    Hagiwara, Masayuki
    Kosaka, Takeo
    Takeda, Toshikazu
    Yasumizu, Yota
    Tanaka, Nobuyuki
    Morita, Shinya
    Mizuno, Ryuichi
    Shinojima, Toshiaki
    Hara, Satoshi
    Asanuma, Hiroshi
    Oya, Mototsugu
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2021, 26 (04) : 744 - 752
  • [4] Impact of laparoscopic radical prostatectomy on clinical T3 prostate cancer: experience of a single centre with long-term follow-up
    Gozen, Ali S.
    Akin, Yigit
    Ates, Mutlu
    Hruza, Marcel
    Rassweiler, Jens
    BJU INTERNATIONAL, 2015, 116 (01) : 102 - 108
  • [5] RADICAL PROSTATECTOMY FOR CARCINOMA OF THE PROSTATE - LONG-TERM FOLLOW-UP OF 115 PATIENTS
    FROHMULLER, H
    THEISS, M
    WIRTH, MP
    EUROPEAN UROLOGY, 1991, 19 (04) : 279 - 283
  • [6] Long-term results of radical prostatectomy with immediate adjuvant androgen deprivation therapy for pT3N0 prostate cancer
    Sato, Yuzuri Tsurumaki
    Fukuhara, Hiroshi
    Suzuki, Motofumi
    Fujimura, Tetsuya
    Nakagawa, Tohru
    Nishimatsu, Hiroaki
    Kume, Haruki
    Morikawa, Teppei
    Fukayama, Masashi
    Homma, Yukio
    BMC UROLOGY, 2014, 14
  • [7] 'Vanishing' prostate cancer in radical prostatectomy specimens: incidence and long-term follow-up in 38 cases
    Bostwick, DG
    Bostwick, KC
    BJU INTERNATIONAL, 2004, 94 (01) : 57 - 58
  • [8] Comparative effectiveness of radical prostatectomy and curative radiotherapy in localized prostate cancer: long-term follow-up
    Tamada, Satoshi
    Ninomiya, Noriko
    Kitamoto, Koichiro
    Kato, Minoru
    Yamasaki, Takeshi
    Iguchi, Taro
    Ohmachi, Tetsuji
    Nakatani, Tatsuya
    JOURNAL OF RADIATION RESEARCH, 2017, 58 (04) : 552 - 558
  • [9] Long-term Outcomes of Salvage Lymph Node Dissection for Clinically Recurrent Prostate Cancer: Results of a Single-institution Series with a Minimum Follow-up of 5 Years
    Suardi, Nazareno
    Gandaglia, Giorgio
    Gallina, Andrea
    Di Trapani, Ettore
    Scattoni, Vincenzo
    Vizziello, Damiano
    Cucchiara, Vito
    Bertini, Roberto
    Colombo, Renzo
    Picchio, Maria
    Giovacchini, Giampiero
    Montorsi, Francesco
    Briganti, Alberto
    EUROPEAN UROLOGY, 2015, 67 (02) : 299 - 309
  • [10] Long term follow-up of stages T2-T3 prostate cancer pretreated with androgen ablation therapy prior to radical prostatectomy
    Lee, F
    Siders, DB
    McHug, TA
    Solomon, MH
    Klamerus, ML
    ANTICANCER RESEARCH, 1997, 17 (3A) : 1507 - 1510